Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022

Randy YeeComments to Author , David Carranza, Christine Kim, James Phillip Trinidad, James L. Tobias, Roma Bhatkoti, and Sachiko Kuwabara
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R. Yee, D. Carranza, C. Kim, J.L. Tobias, R. Bhakoti, S. Kuwabara); US Department of Health and Human Services Coordination Operations and Response Element, Washington, DC (J.P. Trinidad)

Main Article

Figure 1

COVID-19 vaccination site accessibility, Atlanta metropolitan area, Georgia, USA, December 11, 2020–March 29, 2022. A) Adult population density; B) COVID-19 providers; C) COVID-19 vaccination site accessible by 15-minute walk; D) 30-minute walk; E) 45-minute walk; F) 60-minute walk. Scale bar indicates 20 km.

Figure 1. COVID-19 vaccination site accessibility, Atlanta metropolitan area, Georgia, USA, December 11, 2020–March 29, 2022. A) Adult population density; B) COVID-19 providers; C) COVID-19 vaccination site accessible by 15-minute walk; D) 30-minute walk; E) 45-minute walk; F) 60-minute walk. Scale bar indicates 20 km.

Main Article

1These first authors contributed equally to this article.

Page created: March 28, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external